US stocks end at fresh records as jobs data boosts stimulus odds | Inquirer Business

US stocks end at fresh records as jobs data boosts stimulus odds

/ 06:36 AM February 06, 2021


NEW YORK, United States  – Wall Street stocks scaled new heights Friday as a lackluster US jobs report was seen as bolstering the case for US President Joe Biden’s $1.9-trillion stimulus plan.

The S&P 500 and the Nasdaq ended at records for a second straight day following the jobs data. Analysts also cited progress on coronavirus vaccines as a factor in extending the rally.


The closely-watched jobs data showed the unemployment rate dropped to 6.3 percent in January but the economy added only 49,000 jobs, the Labor Department said.

Stephen Innes, chief global markets strategist at Axi, called the report a “double clunker” as the December figure was revised to show a loss of 227,000 jobs from an initial estimate of 140,000.


Biden argued the data show the need for speedy relief.

“I see enormous pain in this country, a lot of folks out of work, a lot of folks going hungry,” the US president said in a White House speech.

“I believe the American people are looking right now to their government for help… so I’m going to act. I’m going to act fast.”

Economist Joel Naroff expects Washington to produce another relief package “within the next few weeks,” he said in a note.

“The economy is being supported by the federal government and the markets are reaping the rewards,” Naroff wrote.

In Europe, Paris ended the day with gains, but Frankfurt and London slipped into the red.

Meanwhile, oil prices continued to climb on rising demand expectations as people return to more normal lives.


“WTI and Brent crude oil hit their highest levels since February last year on continued worries about supply coupled with a belief the world economy is going to improve this year, and therefore demand for oil will rise,” said David Madden at CMC Markets UK.

On the corporate front Friday, Chinese short-video app company Kuaishou — a major rival to TikTok — nearly tripled on its market debut following a $5.4-billion initial public offering that was the biggest for an internet firm since Uber’s May 2019 listing.

Johnson & Johnson rose 1.5 percent after it submitted an application for emergency authorization of its Covid-19 vaccine with US health authorities.

The process could take several weeks, but if approved, the vaccine would be the third authorized in the United States, after those of Pfizer-BioNTech and Moderna.

Key figures around 2200 GMT 

New York – Dow: UP 0.3 percent at 31,148.24 (close)

New York – S&P 500: UP 0.4 percent at 3,886.83 (close)

New York – Nasdaq: UP 0.6 percent at 13,856.30 (close)

London – FTSE 100: DOWN 0.2 percent at 6,489.33 (close)

Frankfurt – DAX 30: DOWN less than 0.1 percent at 14,056.72 (close)

Paris – CAC 40: UP 0.9 percent at 5,655.77 (close)

EURO STOXX 50: UP 0.4 percent at 3,655.77 (close)

Tokyo – Nikkei 225: UP 1.5 percent at 28,779.19 (close)

Hong Kong – Hang Seng: UP 0.6 percent at 29,288.68 (close)

Shanghai – Composite: DOWN 0.2 percent at 3,496.33 (close)

Euro/dollar: UP at $1.2048 from $1.1964 at 2200 GMT

Dollar/yen: DOWN at 105.38 yen from 105.54 yen

Pound/dollar: UP at $1.3735 from $1.3672

Euro/pound: UP at 87.71 pence from 87.51 pence

Brent North Sea crude: UP 0.8 percent at $59.34 per barrel

West Texas Intermediate: UP 1.1 percent at $56.85 per barrel


Subscribe to our business newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: markets, shares, Stock Market, US, US stocks, Wall Street
For feedback, complaints, or inquiries, contact us.

Subscribe to our business news

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.